Immunotech Biopharm Ltd financials at a glance
| Year | Year | 2020 | 2021 | 2022 | 2019 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
HK$0.00M | HK$0.00M | HK$0.00M | HK$0.00M | HK$0.00M | HK$0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
HK$0.00 | |||||
| Div. | Dividends |
|
HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
514.58m | 514.58m | 514.58m | 0m | 0m | 0m |
| OCF | Operating Cash Flow |
|
HK$-263.67M | HK$-254.65M | HK$-180.92M | HK$-95.47M | HK$0.00M | HK$0.00M |
| FCF | Free Cash Flow |
|
HK$-288.70M | HK$-400.66M | HK$-249.07M | HK$-109.23M | HK$0.00M | HK$0.00M |
| FCFS | Free Cash Flow Per Share |
|
HK$-0.65 | HK$-0.82 | HK$-0.50 | HK$-0.31 | HK$0.00 | HK$0.00 |